LIPA and metabolic dysfunction-associated steatotic liver disease: The widespread accessibility of reliable diagnostic tests, and the availability of a specific therapy, have inevitably raised the question of whether LAL activity is also altered in more common forms of liver steatosis, namely non-alcoholic fatty liver disease (NAFLD).